09:22 AM EDT, 04/09/2025 (MT Newswires) -- Microbot Medical ( MBOT ) said Wednesday that robotic endovascular procedures using its Liberty robotic system are feasible and significantly minimize radiation exposure, based on data from a study.

According to the study, successful robotic navigation was achieved in 20 cases, meeting its primary endpoint, the company said.

The study also resulted in a mean 92% reduction in radiation exposure.

The company said it may now move to building commercial capabilities and launch preparation, according to its President and CEO Harel Gadot.

Microbot Medical ( MBOT ) shares were up over 33% in premarket trading Wednesday.

Price: 1.86, Change: +0.47, Percent Change: +33.80